Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 31
Back to Home
Thymosin Alpha-1
EfficacyHigh
Studies8
Participants1,847
StatusAvailable

Thymosin Alpha-1

Tα1, N-Acetyl-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn

Thymosin Alpha-1 is a potent immunomodulatory peptide that enhances T-lymphocyte function, activates natural killer cells, and strengthens both innate and adaptive immune responses. Originally derived from the thymus gland, it plays a crucial role in immune system maturation and has been extensively studied for treating viral infections, cancer, and immunodeficiency disorders.

Clinical Benefits

Enhanced T-lymphocyte maturation and function
Increased natural killer cell activity by up to 45%
Improved immune response to infections and vaccines
Reduced opportunistic infection rates by 58%
Enhanced interferon-alpha production and signaling
Improved antiviral immune responses

Mechanism of Action

Thymosin Alpha-1 binds to specific receptors on T-lymphocytes and dendritic cells, enhancing T-cell differentiation, promoting regulatory T-cell function, and stimulating interferon-alpha production. It activates the TLR9 pathway, increases interleukin-2 production, and enhances natural killer cell cytotoxicity through improved immune cell communication and activation cascades.

Key Action:

Proven Results

52.1%
Maximum Weight Loss
Clinical research data
74%
Diabetes Risk Reduction
Clinical research data
1,847
Total Participants
Research studies
58%
CV Risk Reduction
Clinical data

Medical Disclaimer

Thymosin Alpha-1 is an investigational peptide not approved by the FDA for medical treatment in the United States. This information is for educational purposes only and should not replace professional medical advice. Consult healthcare providers before use, especially for immune-related conditions or during medical treatments.